STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 3] ATAI Life Sciences N.V. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Atai Beckley N.V. (ATAI) reported an insider status update: a director filed a Form 3 for an event dated 11/05/2025.

The filing states no securities are beneficially owned. It was filed by one reporting person, with execution by an attorney-in-fact pursuant to Exhibit 24 (Power of Attorney).

Positive
  • None.
Negative
  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
HERSHBERG ROBERT

(Last) (First) (Middle)
C/O ATAI BECKLEY N.V.
PROF. J.H. BAVINCKLAAN 7

(Street)
AMSTERDAM P7 1183AT

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/05/2025
3. Issuer Name and Ticker or Trading Symbol
Atai Beckley N.V. [ ATAI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney.
No securities are beneficially owned.
/s/ Ryan Barrett, as attorney-in-fact 11/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ATAI disclose in this Form 3 filing?

A director filed a Form 3 and reported no securities beneficially owned as of the event date.

What is the event date in ATAI’s Form 3?

The event date is 11/05/2025.

Who filed the Form 3 for ATAI?

It was filed by one reporting person, executed by Ryan Barrett as attorney-in-fact under Exhibit 24.

Does the ATAI director own any ATAI shares according to this filing?

No. The Form 3 states no securities are beneficially owned.

What is Exhibit 24 referenced in the filing?

It is a Power of Attorney authorizing the attorney-in-fact to sign the form.

What relationship does the reporting person have to ATAI?

The reporting person is a Director of Atai Beckley N.V.
Atai Beckley Inc

NASDAQ:ATAI

ATAI Rankings

ATAI Latest News

ATAI Latest SEC Filings

ATAI Stock Data

1.58B
242.21M
7.7%
39.81%
8.03%
Biotechnology
Pharmaceutical Preparations
Link
Germany
AMSTELVEEN